Cargando…
Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer
Previous studies developed prognostic signatures largely depended on transcriptome profiles. The purpose of our present study was to develop a proteomic signature to optimize the evaluation of prognosis of colon cancer patients. The proteomic data of colon cancer patient cohorts were downloaded from...
Autores principales: | Shan, Zezhi, Luo, Dakui, Liu, Qi, Cai, Sanjun, Wang, Renjie, Ma, Yanlei, Li, Xinxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974900/ https://www.ncbi.nlm.nih.gov/pubmed/33758598 http://dx.doi.org/10.7150/jca.50630 |
Ejemplares similares
-
A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020) -
The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021) -
Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021) -
Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019) -
P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
por: Liu, Qi, et al.
Publicado: (2018)